The 2024 Adverse Event Reporting Guidelines are now available.

The EPHMRA AER Guidelines have been written for Marketing Authorisation Holders (MAH/CH) or Certificate Holders and market research agencies (MRA) on the collection and reporting of an Adverse Event (AE) of medicinal products and medical devices.

You can view the guidelines by clicking here: https://lnkd.in/ep2rrY4Y